Bright Minds Biosciences Inc. SEC filings DRUG
Bright Minds Biosciences Inc. has 180 filings in SEC EDGAR's recent list, going back to Oct 6, 2020. Its latest annual report, Form 40-F, was filed on Dec 23, 2025 for the period ended Sep 30, 2025. The most recent current report (Form 6-K) was filed on Nov 2, 2026. The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 40-F | Annual report (Canadian issuer) | Dec 23, 2025 | Sep 30, 2025 |
| 20-F | Annual report (foreign issuer) | Dec 31, 2024 | Sep 30, 2024 |
| 20-F | Annual report (foreign issuer) | Dec 29, 2023 | Sep 30, 2023 |
| 20-F | Annual report (foreign issuer) | Dec 29, 2022 | Sep 30, 2022 |
| 20-F/A | Amended annual report (foreign issuer) | Jan 18, 2022 | Sep 30, 2021 |
| 20-F | Annual report (foreign issuer) | Dec 29, 2021 | Sep 30, 2021 |
Showing 6 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- DRUG (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- British Columbia, Canada
- Headquarters
- Chicago, IL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1827401
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.